SE8802413L - Polypeptider - Google Patents

Polypeptider

Info

Publication number
SE8802413L
SE8802413L SE8802413A SE8802413A SE8802413L SE 8802413 L SE8802413 L SE 8802413L SE 8802413 A SE8802413 A SE 8802413A SE 8802413 A SE8802413 A SE 8802413A SE 8802413 L SE8802413 L SE 8802413L
Authority
SE
Sweden
Prior art keywords
hydrogen
alkyl
image
sugar residue
alkylene
Prior art date
Application number
SE8802413A
Other languages
Unknown language ( )
English (en)
Other versions
SE8802413D0 (sv
Inventor
R Albert
W Bauer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8802413D0 publication Critical patent/SE8802413D0/sv
Publication of SE8802413L publication Critical patent/SE8802413L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8802413A 1987-06-29 1988-06-28 Polypeptider SE8802413L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (2)

Publication Number Publication Date
SE8802413D0 SE8802413D0 (sv) 1988-06-28
SE8802413L true SE8802413L (sv) 1988-12-30

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802413A SE8802413L (sv) 1987-06-29 1988-06-28 Polypeptider

Country Status (15)

Country Link
JP (1) JPS6426599A (sv)
KR (1) KR890000520A (sv)
AU (1) AU1840988A (sv)
BE (1) BE1002663A4 (sv)
CH (1) CH679045A5 (sv)
DK (1) DK353788A (sv)
ES (1) ES2010283A6 (sv)
FR (1) FR2617171B1 (sv)
GB (1) GB2206352B (sv)
IL (1) IL86876A0 (sv)
IT (1) IT1221065B (sv)
LU (1) LU87262A1 (sv)
NL (1) NL8801640A (sv)
NZ (1) NZ225188A (sv)
SE (1) SE8802413L (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
EP1198478B1 (en) * 2000-07-31 2005-03-23 Dabur Research Foundation Somatostatin analogs and their use for the treatment of cancer
HUP0401535A3 (en) 2001-03-08 2009-07-28 Univ Tulane Somatostatin antagonists and their use
EP1397150A4 (en) * 2001-04-09 2005-01-26 Administrators Ofthe Tulane Ed AGONISTS OF SOMATOSTATIN
KR100432178B1 (ko) * 2002-01-29 2004-05-22 홍수천 철제배관의 부식방지능을 갖는 수정화 장치
KR100462968B1 (ko) * 2002-06-10 2004-12-23 주식회사 리독스 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
NZ225188A (en) 1991-04-26
BE1002663A4 (fr) 1991-04-30
KR890000520A (ko) 1989-03-15
DK353788D0 (da) 1988-06-27
IT8848133A0 (it) 1988-06-28
FR2617171A1 (fr) 1988-12-30
GB2206352B (en) 1990-10-31
IT1221065B (it) 1990-06-21
GB8815257D0 (en) 1988-08-03
FR2617171B1 (fr) 1994-10-14
IL86876A0 (en) 1988-11-30
CH679045A5 (sv) 1991-12-13
DK353788A (da) 1988-12-30
AU1840988A (en) 1989-01-05
JPS6426599A (en) 1989-01-27
LU87262A1 (fr) 1989-03-08
GB2206352A (en) 1989-01-05
SE8802413D0 (sv) 1988-06-28
ES2010283A6 (es) 1989-11-01
NL8801640A (nl) 1989-01-16

Similar Documents

Publication Publication Date Title
SE8802413L (sv) Polypeptider
IE821270L (en) Cylohexanedione derivatives
EP0176034A3 (en) Diaryl acetylenes, their preparation and use
BG104499A (en) Retinoic acid mimetic anilides
ES2000602A6 (es) Procedimiento para la preparacion de nuevos peptidos relacionados con la calcitonina
NZ220087A (en) Heterocyclic acetyl sulphonamides and herbicidal compositions
NO164546C (no) 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, og antikonsepsjonsmidler inneholdende disse.
BE895534A (fr) Compositions tinctoriales a base de precurseurs de colorants d'oxydation et d'orthonitraniles n-substituees comprenant une alcanolamine et un bisulfite alcalin
EP0107733A4 (en) CYCLOALIPHATIC MEDICINE COMPOSITIONS.
FR2597179B1 (fr) Gaine d'etancheite a soufflet pour joint articule
ES8706137A1 (es) Procedimiento para la obtencion de nuevas benzamidas
ES8705853A1 (es) Un procedimiento para la produccion de derivados de benzoilurea
IL119297A (en) 2,3-Dihydroxypropyl-2-(1-oxoalkyl) amino-2-deoxyglucopyranosides a process for their preparation and compositions containing them
IL65556A0 (en) Pharmaceutical compositions containing n-(aryloxyalkyl)-n'-(amino-alkyl)ureas or salts thereof and some such novel compounds
SE9000691L (sv) Vasoaktiva vasotocinderivat
FR2624141B1 (fr) Dispositif pour l'insertion automatique d'une bande elastique plate dans les coins d'un drap-housse
ES8607224A1 (es) Un procedimiento para preparar esteres de acidos (alquilsulfonil)-metanosulfonicos
ATE44875T1 (de) 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln.
IL74140A0 (en) Substituted n-((amino)alkyl)-1-pyrrolidine,-1-piperidine and-1-homopiperidinecarboxamides and pharmaceutical compositions containing them
CS78482A2 (en) Zpusob vyroby novych s,s'-alkylen-di(dithioalkanolu),-di(dithioalkanolniznich alkyletheru)a -di(dithioalkanolesteru
GR3001784T3 (en) Amino compounds and fungicides containing them
ES8507563A1 (es) Procedimiento para la obtencion de un derivado de arganofosfato
NZ192103A (en) Fungicidal compositions containing a carboximide and n,n-dimethyl-n'-phenyl-n'-fluorodichloromethylthio-sulfamide folpet captan or tolyfluanid
JO1010B1 (en) A method for the preparation of sulfuronylureas and pharmaceutical preparations containing these compounds and their uses
DE3162447D1 (en) Pesticide agents

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8802413-8

Effective date: 19930101

Format of ref document f/p: F